BioWorld

July 24, 1992

View Archived Issues

IMMUNEX, HOECHST BURY THE HATCHET

Read More

EYE TREATMENT ENTERS PHASE III

Read More

CAMBRIDGE BIOTECH FORMS JOINT VENTURE

Read More

CYTRX BURN DRUG ENTERS PHASE II

Read More

ARCTURUS RAISES $3.5 MILLION

Read More

MMD EXTENDS PACT WITH AFFYMAX

Read More